The company uses natural sources to develop microbial therapeutics that treat chronic inflammation and improve human health. Solarea generates a large database of microbial genomic sequences from healthy foods and uses computational approaches to identify synergistic combinations of bacteria, fungi, and prebiotic fibers with powerful anti-inflammatory capabilities. Its first application aims to aid in the dietary management of osteopenia and osteoporosis in postmenopausal women. Solarea's breakthrough came from the discovery of an untapped source of microorganisms with probiotic potential in healthy foods, and its founders established a link between these microorganisms and their applications in inflammatory processes. The company was founded in 2017 by a group of scientists and entrepreneurs in Cambridge, Massachusetts.